Virtu Financial LLC Cellectar Biosciences, Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$3.5 - $6.9 $54,043 - $106,542	15,441 New	15,441 $6,000
Q1 2022 May 17, 2022	SELL	$4.6 - $7.8 $172,486 - $292,476	-37,497 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$6.1 - $10.2 $228,731 - $382,469	37,497 New	37,497 $25,000
Q3 2021 Nov 12, 2021	SELL	$8.2 - $12.4 $408,195 - $617,272	-49,780 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$11.8 - $18.2 $587,404 - $905,996	49,780 New	49,780 $59,000
Q1 2021 May 19, 2021	SELL	$15.2 - $25.0 $3.45 Million - $5.67 Million	-226,837 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$11.2 - $27.7 $2.54 Million - $6.28 Million	226,837 New	226,837 $472,000

Ticker CLRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 6,114,290
Market Cap $13M
Description
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's ma...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.